Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weidong Han

Showing results (291-300 of 392) with videos related to

Pageof 40
Sort By:
Cancer Medicine|November 14, 2023
Outcomes and risk factors of SARS-CoV-2 omicron variant in B-cell lymphoma patients following CD19 targeted CAR-T therapyXibin Xiao, Panpan Chen, Yadi Zhong, et al.
Theranostics|November 8, 2017
Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug CombinationsHangxiang Wang, Jianmei Chen, Chang Xu, et al.
Cell Death & Disease|July 11, 2018
Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic miceYaqi Yin, Haojie Hao, Yu Cheng, et al.
Stem Cells International|July 12, 2017
Preferred M2 Polarization by ASC-Based Hydrogel Accelerated Angiogenesis and Myogenesis in Volumetric Muscle Loss RatsHong Huang, Jiejie Liu, Haojie Hao, et al.
American Journal of Hematology|March 10, 2026
Five-Year Follow-Up: Tandem CD19/CD20 CAR T Therapy Enduring Impact on Refractory/Relapsed Non-Hodgkin LymphomaFuxin Han, Yadi Zhong, Chuan Tong, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|June 6, 2026
The TNFR2<sup>M196R</sup> germline variant confers dual impact on CAR-T cell immunotherapy by enhancing T-cell survival and tumor proliferationNan Liu, Lu Han, Yuting Lu, et al.
Scientific Reports|October 21, 2014
Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanibHongming Pan, Zhanggui Wang, Liming Jiang, et al.
Cancer Medicine|April 11, 2022
Efficacy and safety of PD-1 inhibitor combined with antiangiogenic therapy for unresectable hepatocellular carcinoma: A multicenter retrospective studyJunlin Yao, Xudong Zhu, Zhiheng Wu, et al.
Theranostics|November 18, 2020
YTHDF1-enhanced iron metabolism depends on TFRC m<sup>6</sup>A methylationJing Ye, Zhanggui Wang, Xiaozhen Chen, et al.
Scientific Reports|October 8, 2020
Author Correction: Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanibHongming Pan, Zhanggui Wang, Liming Jiang, et al.
Pageof 40

Showing results (291-300 of 392) with videos related to

Sort By:
Pageof 40
Cancer Medicine|November 14, 2023
Outcomes and risk factors of SARS-CoV-2 omicron variant in B-cell lymphoma patients following CD19 targeted CAR-T therapyXibin Xiao, Panpan Chen, Yadi Zhong, et al.
Theranostics|November 8, 2017
Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug CombinationsHangxiang Wang, Jianmei Chen, Chang Xu, et al.
Cell Death & Disease|July 11, 2018
Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic miceYaqi Yin, Haojie Hao, Yu Cheng, et al.
Stem Cells International|July 12, 2017
Preferred M2 Polarization by ASC-Based Hydrogel Accelerated Angiogenesis and Myogenesis in Volumetric Muscle Loss RatsHong Huang, Jiejie Liu, Haojie Hao, et al.
American Journal of Hematology|March 10, 2026
Five-Year Follow-Up: Tandem CD19/CD20 CAR T Therapy Enduring Impact on Refractory/Relapsed Non-Hodgkin LymphomaFuxin Han, Yadi Zhong, Chuan Tong, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|June 6, 2026
The TNFR2<sup>M196R</sup> germline variant confers dual impact on CAR-T cell immunotherapy by enhancing T-cell survival and tumor proliferationNan Liu, Lu Han, Yuting Lu, et al.
Scientific Reports|October 21, 2014
Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanibHongming Pan, Zhanggui Wang, Liming Jiang, et al.
Cancer Medicine|April 11, 2022
Efficacy and safety of PD-1 inhibitor combined with antiangiogenic therapy for unresectable hepatocellular carcinoma: A multicenter retrospective studyJunlin Yao, Xudong Zhu, Zhiheng Wu, et al.
Theranostics|November 18, 2020
YTHDF1-enhanced iron metabolism depends on TFRC m<sup>6</sup>A methylationJing Ye, Zhanggui Wang, Xiaozhen Chen, et al.
Scientific Reports|October 8, 2020
Author Correction: Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanibHongming Pan, Zhanggui Wang, Liming Jiang, et al.
Pageof 40